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the possible risks of aortic leaflet injury caused by the knots.
Subsequently, the diseased section of the lateral wall along
the incision was excluded, and the incision was closed in
a double-layered fashion with felt strips to achieve PLV
(Video E1). The aortic crossclamp time was 135 minutes,
and the cardiopulmonary bypass time was 241 minutes.
The postoperative course was uneventful, and the postoper-
ative echocardiogram showed improved LV shape/
dimension and function (LVDd ¼ 57 mm, LVEF ¼ 30%)
with no mitral, tricuspid, or aortic regurgitation. She was dis-
charged, able to walk, on postoperative day 49. Three years
after the operation, she is doing well; her cardiac status is
NYHA class I, LVDd is 56 mm, and LVEF is 33%.
DISCUSSION
To the best of our knowledge, this is the first report de-
scribing a case wherein dual SVRs were successfully per-
formed for the reconstruction of the diseased basal septum
and LV lateral wall in a patient with sarcoidosis-induced
dilated cardiomyopathy.
Although cardiac sarcoidosis and idiopathic cardiomyop-
athy have many features in common, the important differ-
ence is that the former often involves multiple and patchy
LV segments, most frequently in the anterior LV wall and
interventricular septum.1 SVR is reported to be an effective
therapeutic option for cardiac sarcoidosis.2 Further, in pa-
tients with both anterior and septal LV involvement, septal
anterior ventricular exclusion is the method of choice in
SVR because it offers low operative mortality and a favor-
able long-term outcome.2,3 Nevertheless, the septal anterior
ventricular exclusion method is limited in that it inevitably
requires an incision along the anterior LV wall for recon-
struction of the interventricular septum3; thus, it can barely
be applied in patients with a diseased septum and an intact
anterior wall. In our case, the basal septum and the lateral
wall were diseased and the anterior wall was intact.
A permanent AV sequential pacemaker may be necessary
postoperatively when conduction disturbance is induced by
the periannular stitches taken along the right coronary cusp;
however, this is not an issue when the patient already has
a pacemaker implanted or is willing to undergo implantation.
In our case, complete AV block was already treated by per-
manent pacemaker implantation. In such cases, the surgeon
can reconstruct the basal septum through the ventriculotomy
at the lateral LV wall to achieve PLV without the concern of
damaging the conduction system around the aortic annulus
and consequently decrease the enlarged LV diameter while
preventing possible future ventricular septal perforation.
In conclusion, we have reported a case wherein dual SVRs
were successfully performed in a patient with cardiac sarcoid-
osis. This novel method wherein a patch is placed on the
scarred basal septum through a ventriculotomy for PLV at
the diseased lateral wall was effective in the surgical treatment
of dilated cardiomyopathy involving multiple and patchy LV
segments. The long-term outcome of this treatment remains
unknown2,3; hence, a careful follow-up is mandatory.
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gerous complication after acute myocardial infarction with
regard to both natural history and surgical treatment. VSD
appears in 1% to 2% of patients after a myocardial infarc-
tion. Prognosis is poor, with only 75% of untreated patients
surviving after 24 hours, 50% after 1 week, 30% after 2
weeks, and only 15% after 30 days.1 The literature describes
different outcomes depending on whether the corrective op-
eration is performed promptly or deferred; mortality is 67%rgery c May 2009
Brief Communicationsif surgery is performed in the first week after postinfarction
VSD develops, 75% if in the second week, and 17% after
that.2
CLINICAL SUMMARY
The Impella Recover (ABIOMED, Inc, Danvers, Mass)
is a small intracardiac axial-flow left ventricular assist de-
vice (LVAD) that provides 4 to 5 L/min continuous blood
flow. The device can be set at 10 different speeds, from
10,000 to 33,000 rpm. The Impella is advanced into the
left ventricular cavity in a retrograde fashion through a pros-
thetic graft sutured to the ascending aorta (in the operating
theater) or through the femoral artery (in the catheterization
laboratory), thereby passing the aortic valve.3 The correct
position, essential for the correct function of the device,
can be verified by means of the differential pressure trace
on the console, transesophageal echocardiography, or
fluoroscopy.
Our objective has been to exploit characteristics of this de-
vice to maintain a stable hemodynamic condition in patients
with postinfarct VSD, thus allowing us to postpone surgical
closure of the defect for 3 to 4 weeks (changing the Impella
Recover LVAD if necessary). During this period, myocar-
dium around the defect becomes fibrotic and thus provide
a better footing for a steady suture.
After the Impella implantation, a left ventricular overload
reduction appears. In addition, left-to-right ventricular shunt
decreases and may disappear.
To improve prognosis, is important to implant the Impella
Recover LVAD before excessive worsening of the patient’s
hemodynamic condition. If the LVAD is not available, an
intra-aortic balloon pump is implanted.
In our experience, after implantation of the Impella Re-
cover with the P4 program level (2.5 L/min) the pulmo-
nary/systemic perfusion ratio is lowered, with an average
reduction of 1 without reversal of the shunt to avoid systemic
hypoxia risk. Ascending aortic pressures generally increase,
with average increases of 10 to 15mmHg in both systolic and
diastolic pressures. Pulmonary arterial pressures in our expe-
rience decrease, with an average reduction of 35 to 40 mm
Hg. Wedge pressures also decrease, with an average reduc-
tion of 10 to 15 mm Hg. Moreover, in cases of mitral regur-
gitation there is a relevant reduction of incompetence from
moderate to mild. Furthermore, in every case it has been pos-
sible to significantly reduce inotropic drug infusion, thus
decreasing potential side effects. Other parameters controlled
are the right ventricular stroke work index and the venous
oxygen saturation.
After Impella Recover LVAD implantation, daily trans-
thoracic echocardiography is performed for the firstThe Journal of Thoracic and Ca5 days; after that, echocardiography is performed every
2 days as long as the patient is in stable condition. In the
case of new hemodynamic worsening, we generally
increase the program level (P) on the console. Nevertheless,
once the P7 or P8 program level has been reached, it is im-
portant to consider the possibility of an early operation. On
the other hand, if the patient’s hemodynamic condition re-
mains stable, the operation can be deferred for 3 to 4 weeks,
at which time there is less surgical difficulty in suturing the
patch to thicker and more solid tissue to close the defect.
Surgical closure of the postinfarction VSD may not be
possible, for example after a very wide infarct with a serious
ejection fraction reduction. The Impella Recover LVAD can
then be used as a bridge to transplant, as long as there are no
contraindications.4,5
The management of postischemic VSD requires a simple
protocol to stabilize hemodynamic condition in a short time.
Mechanical support should be as practical and effective, as is
the Impella Recover LVAD. This system is much less inva-
sive than a complete peripheral bypass with oxygenation,
such as extracorporeal membrane oxygenation, in terms of
both the postoperative management and the duration of me-
chanical support.
This new surgical management protocol permits modifi-
cation of the timing of the operation, potentially improving
prognosis after postinfarction VSD. So our experience has
been positive, if limited to a few cases. We report promising
improvements in hemodynamic parameters. Pulmonary ar-
terial pressure, right ventricular stroke work index, venous
oxygen saturation, wedge pressure, transesophageal echo-
cardiographic evaluation of the shunt, and mitral incompe-
tence (if present) are all useful indicators of the patient’s
condition. Our objectives in the future will be to characterize
hemodynamic and echocardiographic cutoffs to evaluate ef-
ficacy of the device and thus decide in a given case whether
to continue with LVAD support, close the defect immedi-
ately, or evaluate the patient for cardiac transplant.
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